Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

被引:20
作者
Giordano, Carla [1 ]
Amato, Marco Calogero [1 ]
Ciresi, Alessandro [1 ]
Citarrella, Roberto [1 ]
Mantione, Lucilla [1 ]
Accidenti, Maria [1 ]
Panto, Felicia [1 ]
Guarnotta, Valentina [1 ]
Allotta, Maria Luisa [1 ]
Criscimanna, Angela [1 ]
Galluzzo, Aldo [1 ]
机构
[1] Univ Palermo, Endocrinol Sect, Ctr Riferimento Reg Diag & Cura Endocrinopatie Au, Dipartimento Med Interna & Med Sperimentale DIBIM, I-90127 Palermo, Italy
关键词
Type; 1; diabetes; Metabolic memory; HbA1c levels; Nephropathy; Retinopathy; Microalbuminuria; BETA-CELL FUNCTION; GLYCEMIC CONTROL; INSULIN-SECRETION; C-PEPTIDE; RETINOPATHY; MICROALBUMINURIA; RISK; NEPHROPATHY; PROGRESSION; GLUCOSE;
D O I
10.1016/j.ejim.2011.02.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods: 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 +/- 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual beta-cell function, beta-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. Results: The probability of developing microalbuminuria was higher in males than in females (HR 1.82; 95% CI 1.01-3.28; p = 0.044), in patients with higher mean HbA1c values (HR 2.80; 95% CI 1.63-4.83; p < 0.001), longer duration of disease (HR 1.98; 95% CI 1.10-3.57; p = 0.022) and younger age of diabetes onset (HR 0.53; 95% CI 0.03-0.92; p = 0.026). An increased probability of developing retinopathy was found in patients with higher mean HbA1c levels during follow-up (HR 2.35; 95% CI 1.34-4.12, p = 0.003), as well as at onset (HR 1.85; 95% CI 1.06-3.24; p = 0.030). Conclusions: Our study suggests that among the clinical, metabolic, immunological and biochemical factors evaluated at onset, only HbA1c is predictive for the microangiopathy development in T1DM. (C) 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 51 条
  • [41] THE EFFECT OF LONG-TERM INTENSIFIED INSULIN-TREATMENT ON THE DEVELOPMENT OF MICROVASCULAR COMPLICATIONS OF DIABETES-MELLITUS
    REICHARD, P
    NILSSON, BY
    ROSENQVIST, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) : 304 - 309
  • [42] Shannon H, 2000, NEW ENGL J MED, V342, P381
  • [43] Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: Role of central obesity
    Sibley, SD
    Thomas, W
    de Boer, I
    Brunzell, JD
    Steffes, MW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (02) : 223 - 232
  • [44] SJOBERG S, 1991, Journal of Diabetic Complications, V5, P18, DOI 10.1016/0891-6632(91)90005-A
  • [45] HOMOGENEITY IN PATTERN OF DECLINE OF BETA-CELL FUNCTION IN IDDM - PROSPECTIVE-STUDY OF 204 CONSECUTIVE CASES FOLLOWED FOR 7.4 YR
    SNORGAARD, O
    LASSEN, LH
    BINDER, C
    [J]. DIABETES CARE, 1992, 15 (08) : 1009 - 1013
  • [46] Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes - The Diabetes Prevention Trial-Type 1
    Sosenko, Jay M.
    Palmer, Jerry P.
    Greenbaum, Carla J.
    Mahon, Jeffrey
    Cowie, Catherine
    Krischer, Jeffrey P.
    Chase, H. Peter
    White, Neil H.
    Buckingham, Bruce
    Herold, Kevan C.
    Cuthbertson, David
    Skyler, Jay S.
    [J]. DIABETES CARE, 2007, 30 (01) : 38 - 42
  • [47] Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
    Sosenko, JM
    Palmer, JP
    Greenbaum, CJ
    Mahon, J
    Cowie, C
    Krischer, JP
    Chase, HP
    White, NH
    Buckingham, B
    Herold, KC
    Cuthbertson, D
    Skyler, JS
    [J]. DIABETES CARE, 2006, 29 (03) : 643 - 649
  • [48] Sosenko JM, 2004, DIABETES, V53, pA425
  • [49] Autoantibodies in type 1 diabetes
    Taplin, Craig E.
    Barker, Jennifer M.
    [J]. AUTOIMMUNITY, 2008, 41 (01) : 11 - 18
  • [50] The rise and fall of insulin secretion in type 1 diabetes mellitus
    Tsai, EB
    Sherry, NA
    Palmer, JP
    Herold, KC
    [J]. DIABETOLOGIA, 2006, 49 (02) : 261 - 270